The Girona Biomedical Research Institute (IDIBGI) has obtained two grants from the AGAUR's Industry of Knowledge call to promote two innovation projects. Both grants have been awarded in the category of Llavor Grants, aimed at those innovations that have the potential to be transferred to the market and society.
One of the projects that has received this aid belongs to the Cardiovascular Genetics research group of the IDIBGI, linked to the Cardiology Service of the Trueta and Santa Caterina Hospitals, which aims to improve the diagnosis of syncope and consequently reduce the number of tests needed to determine the cause. The aim is to identify specific biomarkers in the blood that make it possible to define whether the origin of the episode is cardiac or neurological, so that faster and more appropriate treatment can be offered depending on the case.
The other project to which the grant has been awarded is promoted by IDIBGI's Neurodegeneration and Neuroinflammation research group, linked to the Neurology Service of the Trueta and Santa Caterina Hospitals. This is the EM-Line Kids: a cognitive rehabilitation tool for children suffering from some type of cognitive impairment, neurodevelopmental or learning disorder. This tool will make it possible to personalise the rehabilitation treatment specifically for each case and to carry it out at home, free of charge for the families. It also makes it easier to reconcile these treatments with the daily lives of children and their families.
The IDIBGI's Innovation area promotes innovation and the transfer of knowledge and/or research results in clinical practice to improve people's health, generating a return to society and, at the same time, institutional sustainability.
Photo credit: Dr. Josep Trueta Hospital in Girona.
